In 2021, the Brazilian legislature revoked a controversial article (Article 229-C) in the Brazilian IP Law, ending the participation of ANVISA (the...
Rana Gosain is a Senior Partner at Daniel Law. He has worked with Intellectual Property for more than 30 years. He is an Intellectual Property Agent accredited by the Brazilian PTO and has a postgraduate degree in Intellectual Property from the Pontifical Catholic University in collaboration with the Brazilian PTO.
Rana specializes in patents and industrial design and has great experience of handling patents, litigation strategies, validity and infringement studies and providing legal advice. Much of his work focuses on the pharmaceuticals and biotechnology area.
Rana’s current role is to develop the best strategies for protecting and managing IP Portfolios. He also advises clients on a broad range of issues related to Intellectual Property.
Postgraduate degree in Intellectual Property from the Pontifical Catholic University of Rio de Janeiro.
Affiliations, Commissions and Collegiate
Member of the Brazilian Intellectual Property Association – ABPI;
Member of the Association Internationale pour la Protection de la Propriété Intellectuelle – AIPPI;
Member of the Fédération Internationale des Conseils en Propriété Industrielle – FICPI;
Member of the Licensing Executives Society – LES;
Member of the American Intellectual Property Law Association – AIPLA;
Member of the Director Council from ABPI;
Member of the Brazilian Association of Industrial Property Agents – ABAPI.
Recent IP protection measures in Brazil
Japan is a key strategic partner for Brazil in Asia. The official ties between the two countries can be traced back to the signing of the Treaty of...
Protecting and enforcing design rights: Brazil
In Brazil, the legal provisions for industrial designs are included in the Industrial Property Law (9,279/96). This law is supplemented by normative...
IP law: Brazil’s law must catch up with inventions
Will emerging technologies urge Brazil to rethink its IP laws? Rana Gosain of Daniel Law explores the issues around patents and software-related...
Brazil patent examination: Defying the backlog
Despite a reputation for being slow to grant patents, Brazil’s IP office has introduced a number of programmes to expedite examination—with some...
Innovation Stimulus and Pharma Update In Brazil
The Brazilian Government is bent on stimulating local cutting-edge innovation and thus wants to empower its domestic industry so that these...
Update on Brazil’s pharma patent landscape
Brazil is the eighth largest pharmaceutical market in terms of revenue and Latin America’s largest markets. The consumption of drugs in the retail...
The Brazilian Government may grant 230.000 pending patent applications to eliminate the backlog
The Brazilian Government is considering an emergency measure to eliminate the Patent Office’s chronic backlog problem by automatically granting...
Pulling the plug on INPI’s backlog
Brazil’s government is expected soon to launch an emergency measure to eliminate the Brazilian Patent and Trademark Office’s (INPI) backlog by...